ALLERGAN INC·4

Nov 21, 5:03 PM ET

ALLERGAN INC 4

4 · ALLERGAN INC · Filed Nov 21, 2003

Insider Transaction Report

Form 4
Period: 2003-11-19
Transactions
  • Award

    Phantom Stock Units

    2003-11-19$74.67/sh+13.39$1,00021,090.89 total
    Exercise: $0.00Common Stock (0 underlying)
  • Award

    Phantom Stock Units

    2003-11-20$73.92/sh+40.59$3,00021,131.48 total
    Exercise: $0.00Common Stock (0 underlying)
Footnotes (4)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
  • [F4]Includes phantom stock units accrued under the Allergan, Inc. Dividend Reinvestment Plan.

Documents

1 file
  • 4
    ros230.xmlPrimary